89bio (NASDAQ:ETNB) 报告的季度亏损为每股$(1.02)，低于分析师共识预期的$(0.77)，低32.47%。 与去年同期每股亏损$(0.50)相比，减少了104%。

以上内容来自Benzinga Earnings专栏，原文如下：

89bio (NASDAQ:ETNB) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.77) by 32.47 percent. This is a 104 percent decrease over losses of $(0.50) per share from the same period last year.